Intrenched technologies often lead to a focus on incremental innovation. However, sometimes, radical innovations will allow bold thinkers to leapfrog outdated technologies and mindsets. BD4BO is organizing a seminar on 17 September 2018, you are invited to tune in. This webinar will discuss if CEE countries have an opportunity to harness state-of-the-art technology to bypass legacy process and begin sharing health data to improve patient access to needed new therapies.
Relevant links:
BD4BO, Big Data for Better Outcomes, is an initiative to support the evolution towards patient-centred, outcomes-focused sustainable healthcare systems in Europe, funded by the Innovative Medicines Initiative (IMI), the world's largest public-private partnership for health research. Read more about BD4BO and how HARMONY is involved >>
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
